Economic development creates opportunities to grow state, local and metro areas, which are essential for economic growth, improved quality of life and community development. Merck articles below.
The investment will bring capital improvements, expansion of manufacturing capacity and capabilities, and advanced technology to the company's DeSoto, KS operations.
Merck will invest $275 million in a new research and manufacturing facility in Corsier-sur-Vevey, Switzerland, which will house approximately 250 employees.
The German company, which operates its biopharm business as EMD Serono in the U.S. and Canada, will invest $70 million to expand its Billerica, MA facility.
The $73 million investment is part of wider $1 billion investment that will transform the Darmstadt site into the company’s contemporary global headquarters.
Investment supports growing demand with new biopharmaceutical manufacturing and distribution centers in South Korea and India, accelerates biosimilars manufacturing and development in China.